Tesla Motors Inc (NASDAQ:TSLA) is planning to build a factory in Europe once sales of its electric cars reach 160,000 a year in the region, CEO Elon Musk said. Tesla Motors Inc (NASDAQ:TSLA) net profit margin is -6.50% and weekly performance is 0.24%. On last trading day company shares ended up $203.38. Analysts mean target price for the company is $224.83. Tesla Motors Inc (NASDAQ:TSLA) distance from 50-day simple moving average (SMA50) is 0.11%.
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Director Elaine Ullian sold 2,500 shares of Vertex Pharmaceuticals stock on the open market in a transaction that occurred on Monday, June 9th. The shares were sold at an average price of $75.00, for a total transaction of $187,500.00. Following the transaction, the director now directly owns 5,265 shares in the company, valued at approximately $394,875. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares advanced 0.28% in last trading session and ended the day on $74.24. Gross Margin is 93.40% and its return on assets is -15.30%. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) quarterly performance is -7.25%.
Noble Energy Inc. and Consol Energy Inc. (NYSE:CNX) will form a joint venture to own natural gas pipelines and processing facilities in the Marcellus Shale. CONSOL Energy Inc. (NYSE:CNX) shares moved up 0.97% in last trading session and was closed at $47.00, while trading in range of $46.25 – $47.14. CONSOL Energy Inc. (NYSE:CNX) year to date (YTD) performance is 23.95%.
Noble Corp. plc (NYSE:NE) has named Steven A. Manz to the position of senior vice president and CFO of Paragon Offshore Ltd., the standard specification offshore drilling company to be created upon separation from Noble. He will report to Randall “Randy” Stilley who was named in February to serve as CEO and president of Paragon. Noble Corp plc (NYSE:NE) ended the last trading day at $31.84. Company weekly volatility is calculated as 1.50% and price to cash ratio as 70.57. Noble Corp plc (NYSE:NE) showed a positive weekly performance of 1.43%.
Jack Lief, co-founder, president and CEO of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), said the prescription growth for Belviq, a weight-loss drug has been tremendous. It is FDA-approved and promotional activity from Eisai is boosting in sales, he said.Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) net profit margin is -30.20% and weekly performance is 2.15%. On last trading day company shares ended up $6.18. Analysts mean target price for the company is $7.83. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) distance from 50-day simple moving average (SMA50) is -2.72%.